In this month's episode, our host Dr Muthiah Vaduganathan speaks with Dr Kieran McCafferty, Consultant Nephrologist at Barts NHS Health Trust London, and Senior Clinical Lecturer at Queen Mary University of London, about the growing need for effective management strategies in cardiorenal disease.
After touching on the current epidemiology of co-existing CKD and heart failure (HF), Kieran gives a first-hand assessment on the unique challenges of diagnosing HF in CKD. We discuss the evolution of drug treatment in CKD and how cardiorenal patients are now benefitting from the same classes of agents as HF patients. Finally, we talk about collaborative care and hear about Kieran’s own model for optimising guideline-directed medical therapy in his joint service.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
Listen to more episodes from Heart Failure in Focus.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
The first episode will be launched on 28th August. Watch this space!
This podcast is supported by an unrestricted educational grant from AstraZeneca.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.
Questions can be sent via Twitter to our host @mvaduganathan or to @radcliffeCARDIO.
This podcast is supported by an unrestricted educational grant from AstraZeneca.